Human papillomavirus (HPV) may be a risk factor in developing squamous cell carcinoma, a common form of skin cancer, according to research led by Dartmouth Medical School. The study, publish
Despite recent restrictions placed on work hours for resident physicians, the prevalence of significant depressive symptoms among those new physicians has not decreased. Now researchers from the Univer
Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that th
Patients experiencing high normal blood pressure (HNBP), a precursor to hypertension, may benefit from early treatment with pharmacological therapy, according to new research presented at the American College
Vulnerability to both alcohol and nicotine abuse may be influenced by the same genetic factor, according to a recent study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
A drug that is marketed to treat Alzheimer's disease also improves cognitive function, mood and quality of life in brain tumor patients following radiation therapy, according to a research team at Wake For
Severely obese patients may experience significant, long-term improvements in blood pressure as they lose substantial amounts of weight after gastric bypass surgery, thereby contributing to their overall health, according to a new
High exposure to a fibrous volcanic mineral called erionite was associated with a high incidence of a type of cancer called mesothelioma, according to a study in the Journal of the Nati
Oregon Health & Science University is participating in a national study of a drug that may prevent Alzheimer's disease by blocking an enzyme that produces plaques believed to trigger the disorder.
A new brain chemical test that predicts which patients with heart attack symptoms are at higher risk of dying is paradoxically not being used in younger, healthier patients who could benefit the most from the prognostic information provided by this tes
Date: Monday, 22-Jan-2007
According to a study conducted in five Northern European countries, there is no clear connection between mobile phone use and malignant brain tumours.The results of the study were published in the web version of the International Journal of Cancer on 19th January.
The study on the possible connection between mobile phone use and the risk of a malignant brain tumour, glioma, was carried out in Denmark, Finland, Norway, Sweden and England. The study showed that mobile phone users were not at an increased risk of developing a glioma.
Regular use of a mobile phone, duration of use, or the cumulative number of calls had no effect on the risk. The only indication of a potential effect was found among mobile phone users who had used a mobile phone for at least 10 years. They were found to have a slightly increased risk of a tumour on the side of the head on which they held the phone. Information on mobile phone use was collected using personal interviews. There is always a risk of error associated with recall, which affects the reliability of the results.
The research data from the participating countries was analysed by the Radiation and Nuclear Safety Authority (STUK). Funding for the study in Finland was provided by the Emil Aaltonen Foundation, Academy of Finland and Doctoral Programs for Public Health (DPPH).
The study data collected between 2000 and 2004 included 1,521 glioma patients and 3,301 healthy controls. The number of people who had used a mobile phone for longer than 10 years was higher (222) than in previous studies.
"Even though the results do not indicate that mobile phone use increases the risk of cancer, we need more research data on long-term use," says Anssi Auvinen, Research Professor at the Radiation and Nuclear Safety Authority.
The completion of an extensive international study (INTERPHONE) on the connection between the use of mobile phone and brain tumour based on data collected in 14 countries is expected in the future.
http://www.aka.fi